Who We Are
It takes strong leadership to produce exceptional results.
Our management team is committed to leading our organization according to high standards of quality, integrity and accountability. The TurnPoint leadership team’s mission is to bring innovation to healthcare by creating cost-effective solutions and products while improving the patient healthcare experience.
Our Leadership Team
Christopher J. York
Christopher J. York is one of the most successful entrepreneurs in the Specialty/Home Infusion market. During his 27 year career he has held senior leadership positions in large national companies and has built and consolidated three market leading Specialty Infusion providers. Most recently he built SCP Specialty Infusion, which was acquired by Axelacare Health Solutions, a large nationwide provider of infusion services. Subsequently, Mr York has served on the Board of Directors of Axelacare.
Jerry C. Ruddle
President and CEO
Following an early career in biomedical engineering/technology transfer with NASA, Mr. Ruddle enjoyed a career building and leading a number of new medical device and diagnostic businesses in critical care, cardiology, and resuscitation for the Hewlett Packard Company Medical Products Group, serving customer needs in the hospital non-hospital, transport and military markets. As an entrepreneur, Mr. Ruddle has built and sold several market-leading venture-backed technology companies delivering innovations in the biometric security, advanced materials and government healthcare services markets.
EVP Sales and Strategic Relations
Richard F. Worthen has come to TurnPoint with over 15 years leading Sales and Marketing teams at MSD (Medical Specialties Distributors – the leading distributor of infusion products to the home infusion market). As the EVP of Sales with MSD, Mr. Worthen led the growth of infusion products business tenfold. Richard’s leadership experience also includes sales and marketing management roles with J&J Healthcare and C.R. Bard.
R. Douglas Hulse
R. Douglas Hulse is an Executive Director and Principal at The Sage Group, a leading international consultancy in the field of Pharma, biotech and medical devices. He has to his credit several entrepreneurial businesses he founded, including I-stat, the diagnostic firm that was sold to Abbott Labs for nearly $400 million.
John R. Toedtman
Mr. Toedtman brings senior executive experience with a Fortune 100 company as well as a number of medical diagnostic and device firms. He has served as a Director of seven public and private companies and was the founding CEO of TurnPoint.